Oman's Foreign Minister Sayyid Badr bin Hamad Al Busaidi meets with U.S. Special Envoy Steve Witkoff and U.S. President Donald Trump's son-in-law, Jared Kushner ahead of the indirect U.S.-Iran talks, in Geneva, Switzerland, February 17, 2026. Oman’s Ministry Of Foreign Aff | Via Reuters The next round of talks between the United States and Iran will be Thursday in Geneva, Oman's foreign minister s...
Oman's Foreign Minister Sayyid Badr bin Hamad Al Busaidi meets with U.S. Special Envoy Steve Witkoff and U.S. President Donald Trump's son-in-law, Jared Kushner ahead of the indirect U.S.-Iran talks, in Geneva, Switzerland, February 17, 2026. Oman’s Ministry Of Foreign Aff | Via Reuters The next round of talks between the United States and Iran will be Thursday in Geneva, Oman's foreign minister said Sunday, shortly after Tehran's top diplomat said he expected to meet U.S. envoy Steve Witkoff then. Foreign Minister Badr al-Busaidi said on social media he was pleased to confirm the development, "with a positive push to go the extra mile towards finalizing the deal." Oman previously hosted the indirect talks on the Islamic Republic's nuclear program and facilitated the latest round in Geneva last week. There was no immediate comment from the White House. Foreign Minister Abbas Araghchi had told CBS in an interview aired Sunday that a "good chance" remained for a diplomatic solution on the nuclear issue, adding it was the only matter being discussed. The Trump administration has been pushing for concessions from its longtime adversary and has built up the largest U.S. military presence in the Middle East in decades. President Donald Trump warned on Friday that limited strikes against Iran are possible, even as Araghchi at the time said Tehran expected to have a proposed deal ready in the next few days. Araghchi told CBS that Iran was still working on the draft proposal. He added that Iran has the right to enrich uranium. On Friday, he said his U.S. counterparts had not asked for zero enrichment as part of the latest round of talks, which is not what U.S. officials have said publicly. Both Iran and the U.S. have signaled they are prepared for war if talks on Tehran's nuclear program fail. Minutes after Oman's confirmation of talks, Iranian President Masoud Pezeshkian said on social media that "recent negotiations involved the exchange of practical proposals and yielded ...
Quantum computing is still early, messy, and wildly speculative, which is exactly why the upside for patient, risk‑tolerant investors is so intriguing. If this technology can cross the chasm from lab curiosity to everyday infrastructure over the next 10–20 years, today's niche players could look like buying early cloud or GPU leaders before the world catches on. Here are two quantum names with ve...
Quantum computing is still early, messy, and wildly speculative, which is exactly why the upside for patient, risk‑tolerant investors is so intriguing. If this technology can cross the chasm from lab curiosity to everyday infrastructure over the next 10–20 years, today's niche players could look like buying early cloud or GPU leaders before the world catches on. Here are two quantum names with very different approaches that could, in a bullish scenario, move the needle on lifetime wealth and eventually produce some millionaire investors. Continue reading
Key PointsPerceptive Advisors increased its Apogee Therapeutics position by 978,662 shares; the estimated trade value was $61.64 million (based on quarterly average prices).
Key PointsPerceptive Advisors increased its Apogee Therapeutics position by 978,662 shares; the estimated trade value was $61.64 million (based on quarterly average prices).
On February 17, 2026, Perceptive Advisors disclosed a significant buy of 431,432 shares of Praxis Precision Medicines (NASDAQ:PRAX) , with an estimated transaction value of $80.34 million based on quarterly average pricing, according to its latest SEC filing. According to a February 17, 2026, SEC filing , Perceptive Advisors LLC increased its stake in Praxis Precision Medicines (NASDAQ:PRAX) by 43...
On February 17, 2026, Perceptive Advisors disclosed a significant buy of 431,432 shares of Praxis Precision Medicines (NASDAQ:PRAX) , with an estimated transaction value of $80.34 million based on quarterly average pricing, according to its latest SEC filing. According to a February 17, 2026, SEC filing , Perceptive Advisors LLC increased its stake in Praxis Precision Medicines (NASDAQ:PRAX) by 431,432 shares during the fourth quarter of 2025. The estimated value of this trade was approximately $80.34 million, calculated using the mean unadjusted close price for the period. The quarter-end value of the position increased by $505.38 million, reflecting both the share purchase and subsequent stock price movement. Praxis Precision Medicines is a Boston-based biotechnology company specializing in the development of novel therapies for disorders characterized by neuronal imbalance. With a focused pipeline addressing major depressive disorder, essential tremor, and rare epilepsies, the company leverages proprietary research and strategic collaborations to advance its candidates through clinical stages. Praxis differentiates itself through its emphasis on precision medicine and targeted central nervous system treatments, aiming to address unmet medical needs in neurology and psychiatry. Continue reading
Andrii Dodonov/iStock via Getty Images A series of macro and policy developments is shifting sentiment in the $31 trillion U.S. Treasury market back toward higher yields, Bloomberg News reported Sunday. Treasuries declined last week after a month-long rally, as investors reassessed fiscal and monetary risks. The Supreme Court’s decision to invalidate key Trump-era tariffs may reduce government rev...
Andrii Dodonov/iStock via Getty Images A series of macro and policy developments is shifting sentiment in the $31 trillion U.S. Treasury market back toward higher yields, Bloomberg News reported Sunday. Treasuries declined last week after a month-long rally, as investors reassessed fiscal and monetary risks. The Supreme Court’s decision to invalidate key Trump-era tariffs may reduce government revenue, potentially widening deficits and increasing future bond issuance. At the same time, resilient labor data and firmer inflation readings have lowered expectations for Federal Reserve rate cuts, and even revived discussion of potential tightening if price pressures persist. The combination has supported a move higher in yields, with the 10-year note ending the week around 4.08%, up from recent lows near 4%. Market participants who had positioned for falling yields earlier in the month have begun reversing course. Strategists at several major firms argue the prior rally was driven largely by short-term risk aversion (including equity volatility tied to artificial intelligence concerns and geopolitical tensions in the Middle East) rather than a fundamental shift in growth or inflation dynamics. Options market signals also suggested the bond rally had become stretched. While some geopolitical and financial stability risks could still drive safe-haven demand, many investors now expect rates to remain range-bound, with a bias toward modestly higher yields if economic data stay firm. The 10-year has largely traded between 4% and 4.3% for months, reflecting a stable but not cooling economy. For investors, the key themes to monitor include: Deficit implications from potential tariff rollbacks and refund uncertainties. Fed policy trajectory, especially whether strong employment data delay rate cuts. Oil prices and geopolitical risk, which could influence inflation expectations. Absent a decisive shift in growth or inflation trends, the Treasury market appears locked in a tactica...
DOJ Files To Revoke Citizenship Of Former Mayor Over Alleged Fraud Authored by Matthew Vadum via The Epoch Times (emphasis ours), The Trump administration said Feb. 20 it has filed court papers to strip a former elected official in Florida of U.S. citizenship for allegedly committing fraud during the naturalization process. Immigrants await their turn for green card and citizenship interviews at t...
DOJ Files To Revoke Citizenship Of Former Mayor Over Alleged Fraud Authored by Matthew Vadum via The Epoch Times (emphasis ours), The Trump administration said Feb. 20 it has filed court papers to strip a former elected official in Florida of U.S. citizenship for allegedly committing fraud during the naturalization process. Immigrants await their turn for green card and citizenship interviews at the U.S. Citizenship and Immigration Services (USCIS) Queens office in the Long Island City neighborhood of New York City on May 30, 2013. John Moore/Getty Images The civil legal process against former North Miami Mayor Philippe Bien-Aime was initiated months after the federal government made a policy announcement. In June 2025, the government said it would begin prioritizing the denaturalization of foreign-born citizens who either “illegally procured” naturalization or procured naturalization by “concealment of a material fact or by willful misrepresentation.” Bien-Aime, a native of Haiti, used two identities to secure immigration benefits and eventually obtain U.S. citizenship after unlawfully entering the United States, U.S. Citizenship and Immigration Services (CIS) said in a statement . CIS said the fraud was confirmed by comparing the fingerprints he provided while using the two identities , as part of a joint project carried out by CIS and the U.S. Department of Justice (DOJ). CIS alleged that before he became a U.S. citizen using the name Philippe Bien-Aime, the individual used a fraudulent passport with a switched photo to come to the United States under the name Jean Philippe Janvier. As Janvier, he was ordered deported. He later withdrew his appeal and represented that he had returned to Haiti. In reality, according to CIS, he remained in the United States, used a new name and birthdate, and was married to a U.S. citizen to procure permanent resident status . The marriage was invalid because he was already married to a citizen of Haiti. He also made various false ...
The Mexican army killed the leader of the powerful Jalisco New Generation Cartel, Nemesio Rubén Oseguera Cervantes, "El Mencho," in an operation Sunday, a federal official said. (Image credit: Alejandra Leyva/AP)
The Mexican army killed the leader of the powerful Jalisco New Generation Cartel, Nemesio Rubén Oseguera Cervantes, "El Mencho," in an operation Sunday, a federal official said. (Image credit: Alejandra Leyva/AP)
On February 17, 2026, Perceptive Advisors reported a buy of Celcuity (NASDAQ:CELC) , adding 203,881 shares in the fourth quarter, with an estimated transaction value of $16.76 million based on quarterly average pricing. According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Perceptive Advisors increased its stake in Celcuity by 203,881 shares in the fourth quarter....
On February 17, 2026, Perceptive Advisors reported a buy of Celcuity (NASDAQ:CELC) , adding 203,881 shares in the fourth quarter, with an estimated transaction value of $16.76 million based on quarterly average pricing. According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Perceptive Advisors increased its stake in Celcuity by 203,881 shares in the fourth quarter. The estimated value of this share purchase, based on the period’s average closing price, is $16.76 million. The value of the fund’s position increased by $169.16 million over the quarter, a figure that reflects both the additional shares and price appreciation. Celcuity is a clinical-stage biotechnology company specializing in the development of targeted cancer therapies and companion diagnostics. The company leverages its proprietary CELsignia platform and pipeline drug Gedatolisib to address unmet needs in oncology, particularly for breast and ovarian cancer. Its strategy centers on innovative diagnostic and therapeutic solutions, supported by a license agreement with Pfizer, positioning Celcuity to capitalize on advancements in precision medicine. Continue reading
Two of the most consistent, reliable, and best financial stocks over the past decades -- Visa (NYSE: V) and Moody's (NYSE: MCO) -- have struggled in recent months. Visa, the leading payment processor, has seen its stock price dip some 8% year to date and 10% over the past 12 months. For a stock that has averaged a 16% annualized return over the past 10 years and 19% since it went public in 2008, i...
Two of the most consistent, reliable, and best financial stocks over the past decades -- Visa (NYSE: V) and Moody's (NYSE: MCO) -- have struggled in recent months. Visa, the leading payment processor, has seen its stock price dip some 8% year to date and 10% over the past 12 months. For a stock that has averaged a 16% annualized return over the past 10 years and 19% since it went public in 2008, it is a rare hiccup. Moody's, a leading credit rating agency and financial analytics provider, is off some 12% YTD and 14% over the past year. It has also been a strong performer over the years, averaging a 17% annualized return over the past 10 years and 15% since 2008. Continue reading
Arsenal could feel the breath of Manchester City on their necks and the questions mounting; the anxiety all around them. The draw at Wolves on Wednesday had been a disaster and, with only two Premier League wins in seven, everybody seemed to want to say the same thing. Mikel Arteta and his players were cracking up in their pursuit of the title. This was the soothing tonic they craved, a comfortabl...
Arsenal could feel the breath of Manchester City on their necks and the questions mounting; the anxiety all around them. The draw at Wolves on Wednesday had been a disaster and, with only two Premier League wins in seven, everybody seemed to want to say the same thing. Mikel Arteta and his players were cracking up in their pursuit of the title. This was the soothing tonic they craved, a comfortable and confident dismissal of a Tottenham team desperate to feel a new manager bounce under Igor Tudor. Spurs did show personality to find a Randal Kolo Muani goal for 1-1 in the 34th minute; it was the striker’s first for the club in the league. Continue reading...
Traditional software governance often uses static compliance checklists, quarterly audits and after-the-fact reviews. But this method can't keep up with AI systems that change in real time. A machine learning (ML) model might retrain or drift between quarterly operational syncs. This means that, by the time an issue is discovered, hundreds of bad decisions could already have been made. This can be...
Traditional software governance often uses static compliance checklists, quarterly audits and after-the-fact reviews. But this method can't keep up with AI systems that change in real time. A machine learning (ML) model might retrain or drift between quarterly operational syncs. This means that, by the time an issue is discovered, hundreds of bad decisions could already have been made. This can be almost impossible to untangle. In the fast-paced world of AI, governance must be inline, not an after-the-fact compliance review. In other words, organizations must adopt what I call an “audit loop": A continuous, integrated compliance process that operates in real-time alongside AI development and deployment, without halting innovation. This article explains how to implement such continuous AI compliance through shadow mode rollouts, drift and misuse monitoring and audit logs engineered for direct legal defensibility. From reactive checks to an inline “audit loop” When systems moved at the speed of people, it made sense to do compliance checks every so often. But AI doesn't wait for the next review meeting. The change to an inline audit loop means audits will no longer occur just once in a while; they happen all the time. Compliance and risk management should be "baked in" to the AI lifecycle from development to production, rather than just post-deployment. This means establishing live metrics and guardrails that monitor AI behavior as it occurs and raise red flags as soon as something seems off. For instance, teams can set up drift detectors that automatically alert when a model's predictions go off course from the training distribution, or when confidence scores fall below acceptable levels. Governance is no longer just a set of quarterly snapshots; it's a streaming process with alerts that go off in real time when a system goes outside of its defined confidence bands. Cultural shift is e qually important: Compliance teams must act less like after-the-fact auditors and ...
FEATURE The and indexes both snapped multi-week losing streaks last week, rising 1.5% and 1.1%, respectively. The big news was Friday’s Supreme Court ruling striking down some of President Donald Trump’s tariffs.
FEATURE The and indexes both snapped multi-week losing streaks last week, rising 1.5% and 1.1%, respectively. The big news was Friday’s Supreme Court ruling striking down some of President Donald Trump’s tariffs.
Key PointsPerceptive Advisors sold 1,002,282 Arcellx shares in the fourth quarter; the estimated trade size was $79.96 million based on quarterly average pricing.
Key PointsPerceptive Advisors sold 1,002,282 Arcellx shares in the fourth quarter; the estimated trade size was $79.96 million based on quarterly average pricing.
On February 17, 2026, Perceptive Advisors disclosed a buy of 978,662 shares of Apogee Therapeutics (NASDAQ:APGE) , with an estimated transaction value of $61.64 million based on quarterly average pricing. According to a February 17, 2026, SEC filing , Perceptive Advisors increased its stake in Apogee Therapeutics (NASDAQ:APGE) by 978,662 shares. The estimated transaction value was $61.64 million, ...
On February 17, 2026, Perceptive Advisors disclosed a buy of 978,662 shares of Apogee Therapeutics (NASDAQ:APGE) , with an estimated transaction value of $61.64 million based on quarterly average pricing. According to a February 17, 2026, SEC filing , Perceptive Advisors increased its stake in Apogee Therapeutics (NASDAQ:APGE) by 978,662 shares. The estimated transaction value was $61.64 million, based on the average share price during the fourth quarter of 2025. The fund ended the quarter holding 2,330,651 shares, with the value of the position rising by $122.20 million, reflecting both new purchases and share price appreciation. Apogee Therapeutics, Inc. is a biotechnology company specializing in the development of extended half-life monoclonal antibodies for the treatment of atopic dermatitis and chronic obstructive pulmonary disease. The company leverages a pipeline of differentiated biologic candidates designed to address significant unmet needs in immunology. Apogee's strategy focuses on advancing its clinical programs to commercialization, aiming to establish a competitive position in targeted therapeutic markets. Continue reading
Maximusnd/iStock via Getty Images The following segment was excerpted from the Baron Emerging Markets Fund Q4 2025 Shareholder Letter. Top Contributors & Detractors Top contributors to performance for the quarter Contribution to Return (%) Taiwan Semiconductor Manufacturing Company Limited ( TSM ) 1.37 SK hynix Inc. ( HXSC.F ) 1.00 Samsung Electronics Co., Ltd. ( SSNLF ) 0.83 Sociedad Quimica y Mi...
Maximusnd/iStock via Getty Images The following segment was excerpted from the Baron Emerging Markets Fund Q4 2025 Shareholder Letter. Top Contributors & Detractors Top contributors to performance for the quarter Contribution to Return (%) Taiwan Semiconductor Manufacturing Company Limited ( TSM ) 1.37 SK hynix Inc. ( HXSC.F ) 1.00 Samsung Electronics Co., Ltd. ( SSNLF ) 0.83 Sociedad Quimica y Minera de Chile S.A. ( SQM ) 0.37 ISC Co., Ltd. 0.30 Click to enlarge Semiconductor giant Taiwan Semiconductor Manufacturing Company Limited (TSMC) contributed to performance during the quarter, driven by robust demand for AI chips. We retain conviction that TSMC’s technological leadership, pricing power, and exposure to secular growth markets—including AI and high-performance computing, automotive, 5G, and Internet of Things—will allow the company to sustain strong double-digit earnings growth over the next several years. South Korean memory semiconductor company SK hynix Inc. contributed to performance, as strong AI-driven demand, combined with tight industry supply, has resulted in a dramatic increase in dynamic random-access memory (DRAM) and NAND flash memory pricing and profitability. Memory is a core pillar of the data economy and benefits from structural demand growth as servers, smartphones, PCs, and other devices become increasingly computationally intensive. We believe SK hynix will remain a key beneficiary of rising adoption of High Bandwidth Memory ( HBM ), which leverages advanced packaging to vertically stack DRAM chips, delivering higher bandwidth, improved power efficiency, and a smaller form factor. SK hynix has emerged as the industry leader in cutting-edge HBM due to its superior performance, durability, and heat dissipation. We expect the company to generate strong earnings growth over the next several years, with significant upside from incremental long-term memory demand driven by AI applications. Shares of South Korean conglomerate Samsung Electronics ...
Centerview Partners LLC settled a lawsuit by a former analyst who claimed the boutique investment bank wrongfully fired her for asking to be able to sleep more than eight hours a night. Jury selection had been set to begin Monday morning in the case, which highlighted the grind culture of Wall Street, especially at junior levels. Centerview had taken the position that a need for a full night’s sle...
Centerview Partners LLC settled a lawsuit by a former analyst who claimed the boutique investment bank wrongfully fired her for asking to be able to sleep more than eight hours a night. Jury selection had been set to begin Monday morning in the case, which highlighted the grind culture of Wall Street, especially at junior levels. Centerview had taken the position that a need for a full night’s sleep every night is incompatible with “the essential functions of the analyst role.” Kathryn Shiber sued Centerview in 2021, claiming she was fired just 10 weeks into a three-year analyst program, shortly after she informed the firm that she had mood and anxiety disorders requiring her to sleep at least eight hours a night on a consistent schedule. Shiber, who had been expected to take the stand during the weeklong trial, was seeking $5 million in damages. The bank confirmed Sunday that it had settled the case but declined to discuss the terms. A lawyer for Shiber didn’t immediately respond to an email seeking comment on the settlement. “Centerview has said all along that Ms. Shiber’s legal claims have no merit,” a Centerview spokesperson said in a statement. “We were ready to prove that in court, and are confident we would have prevailed at trial. But we are nonetheless happy to put this distraction behind us and focus on delivering for our clients.” New York-based Centerview was founded in 2006 by veteran dealmakers Blair Effron and Robert Pruzan and has become one of the top mergers and acquisitions advisory firms. It was the sole adviser on Meta Platforms Inc. ’s investment in data-labeling startup Scale AI, and also had roles on other big-ticket transactions last year, including Sycamore Partners ’ $10 billion acquisition of Walgreens Boots Alliance Inc. Shiber, who joined the bank soon after graduating from Dartmouth in 2020, said in her suit that it was a “dream opportunity.” But soon after she started working, she said it became obvious that the firm expected employee...
Investigation under way in to death of Cpl Lucy Wilde, 25, who prince said ‘served with courage and distinction’ Prince William has paid tribute to a young army medic found dead in her barracks who “served with courage and distinction”. Cpl Lucy Wilde, 25, who posted videos on TikTok documenting her daily life in the army, was found dead in her barracks in Warminster, Wiltshire, on 5 February. An ...
Investigation under way in to death of Cpl Lucy Wilde, 25, who prince said ‘served with courage and distinction’ Prince William has paid tribute to a young army medic found dead in her barracks who “served with courage and distinction”. Cpl Lucy Wilde, 25, who posted videos on TikTok documenting her daily life in the army, was found dead in her barracks in Warminster, Wiltshire, on 5 February. An investigation is under way, the Ministry of Defence said. Continue reading...
The Reform UK leader flew to the Maldives for a day despite not having permit to visit nearby archipelago Nigel Farage has been accused of “performing Maga stunts” after claiming the British government stopped him from travelling to the Chagos Islands on a humanitarian mission. The Reform UK leader said he had flown to the Maldives to join a delegation bringing aid to four Chagossians who are tryi...
The Reform UK leader flew to the Maldives for a day despite not having permit to visit nearby archipelago Nigel Farage has been accused of “performing Maga stunts” after claiming the British government stopped him from travelling to the Chagos Islands on a humanitarian mission. The Reform UK leader said he had flown to the Maldives to join a delegation bringing aid to four Chagossians who are trying to establish a settlement on one of the archipelago’s islands to protest against Britain’s plans to transfer control of the territory to Mauritius . Continue reading...
Does your portfolio need some new income investments? Maybe you're looking for a little more certainty -- and defensiveness -- now that a few too many risky growth stocks are overbought as well as overvalued? Whatever your goal is, here's a rundown of my five favorite dividend stocks to buy right now. Image source: Getty Images. Coca-Cola is one of the top go-to dividend names within the consumer ...
Does your portfolio need some new income investments? Maybe you're looking for a little more certainty -- and defensiveness -- now that a few too many risky growth stocks are overbought as well as overvalued? Whatever your goal is, here's a rundown of my five favorite dividend stocks to buy right now. Image source: Getty Images. Coca-Cola is one of the top go-to dividend names within the consumer goods space, and for obvious reasons. Not only is it the biggest beverage company (as measured by market cap), but it owns some of the most entrenched brand names. Continue reading
Rolls-Royce Holdings PLC is set to announce a share buyback worth as much as £1.5 billion ($2 billion), Sky News reported. The aircraft manufacturing company is set to make the announcement on Thursday when they release a report of “record profits” and the “spectacular scale of its turnaround,” Sky News reported Sunday, without attribution. Last February, the company raised its profit guidance, re...
Rolls-Royce Holdings PLC is set to announce a share buyback worth as much as £1.5 billion ($2 billion), Sky News reported. The aircraft manufacturing company is set to make the announcement on Thursday when they release a report of “record profits” and the “spectacular scale of its turnaround,” Sky News reported Sunday, without attribution. Last February, the company raised its profit guidance, reinstated a dividend and announce a buyback of £1 billion ($1.3 billion) of stock. Read More: Rolls-Royce Lifts Profit Goal, Sets £1 Billion Stock Buyback (3)